Cargando…
In Vivo Validation of a Bioinformatics Based Tool to Identify Reduced Replication Capacity in HIV-1
Although antiretroviral drug resistance is common in treated HIV infected individuals, it is not a consistent indicator of HIV morbidity and mortality. To the contrary, HIV resistance-associated mutations may lead to changes in viral fitness that are beneficial to infected individuals. Using a bioin...
Autores principales: | Kitchen, Christina M.R, Krogstad, Paul, Kitchen, Scott G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097495/ https://www.ncbi.nlm.nih.gov/pubmed/21603285 http://dx.doi.org/10.2174/1874431101004010225 |
Ejemplares similares
-
Enfuvirtide antiretroviral therapy in HIV-1 infection
por: Kitchen, Christina MR, et al.
Publicado: (2008) -
Stem-Cell-Based Gene Therapy for HIV Infection
por: Zhen, Anjie, et al.
Publicado: (2013) -
Engineering CAR T Cells to Target the HIV Reservoir
por: Mu, Wenli, et al.
Publicado: (2020) -
The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer
por: Carrillo, Mayra A., et al.
Publicado: (2018) -
Autophagy inducer rapamycin treatment reduces IFN-I–mediated Inflammation and improves anti–HIV-1 T cell response in vivo
por: Mu, Wenli, et al.
Publicado: (2022)